arrow
M

Michaël Mingueneau

biogen inc
H指数:28
被引数:2,741

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Leveraging Kinase Drugs for Neurosciences: Discovery of Selective; CNS-Penetrant Reversible Bruton’s Tyrosine Kinase Inhibitors as Therapeutics for Neuroinflammation

利用激酶药物进行神经科学研究:发现选择性、能穿透中枢神经系统的可逆性布鲁顿酪氨酸激酶抑制剂作为神经炎症的治疗方法

2026-04-070
OA
Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple Sclerosis
2024-05-073
OAAI
Oxidative phosphorylation regulates B cell effector cytokines and promotes inflammation in multiple sclerosis

氧化磷酸化调节b细胞效应细胞因子并促进多发性硬化症的炎症

2024-05-031
PRE
Variability of Primary Sjogren's Syndrome Is Driven by Interferon α and Interferon α Blood Levels Are Associated With the Class II HLA-DQ Locus
2022-11-0225
OA
Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis
2021-11-0421
PREAI
MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response

MOG自身抗体触发严格控制的FcR和BTK驱动的小胶质细胞增殖反应

BRAIN
IF11.7
2021-06-1940
OA
Organotypic Brain Slice Culture Microglia Exhibit Molecular Similarity to Acutely-Isolated Adult Microglia and Provide a Platform to Study Neuroinflammation

器官型脑切片培养小胶质细胞与急性分离的成年小胶质细胞具有分子相似性,并提供了研究神经炎症的平台

2020-12-2141
OAAI
ImmGen at 15
2020-06-2350
OAAI